Publ
2016Feldkamp J, Führer D, Luster M, Musholt TJ, Spitzweg C, Schott M. [Fine Needle Aspiration in the Investigation of Thyroid Nodules.] Dtsch Arztebl Int. 2016 May 20;113(20):353-9. doi: 10.3238/arztebl.2016.0353
Feldkamp J, Schott M. , Gogol M, Quinkler M, Blüher M, Diederich S, Reincke M. [The Choosing Wisely Initiative of the German Society of Internal Medicine : Recommendations of the German Society for Endocrinology and the German Society for Geriatrics] Internist (Berl). 2016 Jun;57(6):532-9. doi: 10.1007/s00108-016-0072-4. German
Allelein S, Schott M .[Thyroid dysfunction]. MMW Fortschr Med. 2016 Apr 21;158 Spec No 1:45-50; quiz 51. doi: 10.1007/s15006-016-7652-z. German. No abstract available.
2015


de Corbière P, Ritzel K, Cazabat L, Ropers J, Schott M, Libé R, Koschker AC, Leboulleux S, Deutschbein T, Do Cao C, Hahner S, Drui D, Miehle K, Caron P, Waldmann J, Chabre O, Quinkler M, Touraine P, Villares Fragoso MC, Bertherat J, Bertagna X, Fassnacht M, Raffin-Sanson ML. Preganancy in Women Previously Treated for an Adrenocortical Carcinoma. J Clin Endocrinol Metab. 2015 Dec;100(12):4604-11.
Thiel A, Reis AC, Haase M, Goh G, Schott M, Willenberg HS, Scholl UI. PRKACA mutations in cortisol-producing adenomas and adrenal hyperplasia: a single-center study of 60 cases. Eur J Endocrinol. 2015 Jun;172(6):677-85.
Lichtenauer UD, Di Dalmazi G, Slater EP, Wieland T, Kuebart A, Schmittfull A, Schwarzmayr T, Diener S, Wiese D, Thasler WE, Reincke M, Meitinger T, Schott M, Fassnacht M, Bartsch DK, Strom TM, Beuschlein. Frequency and clinical correlates of somatic ying yang 1 mutations in sporadic insulinomas. J Clin Endocrinol Metab. 2015 May;100(5):E776-82
Schott M. [Therapy of thyroid nodules]. Dtsch Med Wochenschr. 2015 Apr;140(8):573-7.
2014










Allelein S, Schott M .[Thyroid dysfunction]. MMW Fortschr Med. 2016 Apr 21;158 Spec No 1:45-50; quiz 51. doi: 10.1007/s15006-016-7652-z. German. No abstract available.
Führer D, Mann K, Feldkamp J, Krude H, Spitzweg C, Kratzsch J, Schott M. Thyroid dysfunction in pregnancy. Dtsch Med Wochenschr. 2014 Oct 139(42):2148-52
Ehlers M, Schott M. Hashimoto's thyroiditis and papillary thyroid cancer: are they immunologically linked? Trends Endocrinol Metab. 2014 Oct [Epub ahead of print]
Ehlers M, Allelein S, Haase M, Willenberg HS, Knoefel WT, Schott M.
Circulating Tumor Cells in Patients with Neuroendocrine Neoplasms. Horm Metab Res. 2014 Jul [Epub ahead of print]
Goh G, Scholl UI, Healy JM, Choi M, Prasad ML, Nelson-Williams C, Kuntsman JW, Korah R, Suttorp AC, Dietrich D, Haase M, Willenberg HS, Stålberg P, Hellman P, Akerström G, Björklund P, Carling T, Lifton RP.
Recurrent activating mutation in PRKACA in cortisol-producing adrenal tumors. Nat Genet. 2014 Jun 46(6): 613-617.
Heinze B, Herrmann LJ, Fassnacht M, Ronchi CL, Willenberg HS, Quinkler M, Reisch N, Zink M, Allolio B, Hahner S.
Less common genotype variants of TP53 polymorphisms are associated with poor outcome in adult patients with adrenocortical carcinoma. Eur J Endocrinol. 2014 Apr 10;170(5):707-17. Print 2014.
Anlauf M, Sipos B, Boeck I, Baldus SE, Heikaus S, Krausch M, Knoefel WT, Begum N, Goretzki P, Schott M, Auernhammer CJ, Cremer B, Rinke A, Ezziddin S, Fottner C, Pöpperl G, Lahner H, Hörsch D, Gabbert HE, Komminoth P, Perren A, Klöppel G, Wiedenmann B, Pavel M, Pape U. Neuroendocrine neoplasms of the distal jejunum and ileum. Pathologe. 2014 Mar 28. [Epub ahead of print] German.
Bernecker C, Halim F, Lenz L, Haase M, Nguyen T, Ehlers M, Vordenbaeumen S, Schott M.
microRNA expression in CD4+ and CD8+ T-cell subsets in autoimmune thyroid diseases. Exp Clin Endocrinol Diabetes. 2014 Feb;122(2):107-12. Epub 2014 Feb 19.
Ehlers M, Thiel A, Papewalis C, Domroese A, Stenzel W, Bernecker C, Haase M, Allelein S, Schinner S, Willenberg H, Feldkamp J, Schott M.
Enhanced iodine supplementation alters the immune process in a transgenic mouse model for autoimmune thyroiditis. Thyroid. 2014 Jan 24. [Epub ahead of print]
Cupisti K, Lehwald N, Anlauf M, Riemer J, Werner TA, Krieg A, Witte J, Chanab A, Baldus SE, Krausch M, Raffel A, Herdter C, Schott M, Knoefel WT.
Encapsulation status of papillary thyroid microcarcinomas is associated with the risk of lymph node metastases and tumor multifocality. Horm Metab Res. 2014 Feb;46(2):138-44. Epub 2013 Dec 19.
Krausch M, Raffel A, Anlauf M, Schott M, Lehwald N, Krieg A, Topp SA, Cupisti K, Knoefel WT.
"Cherry picking", a multiple non-anatomic liver resection technique, as a promising option for diffuse liver metastases in patients with neuroendocrine tumours. World J Surg. 2014 Feb;38(2):392-401.
Werminghaus P, Haase M, Hornsby PJ, Schinner S, Schott M, Malendowicz LK, Lammers BJ, Goretzki PE, Müller-Mattheis V, Markus Giessing, Willenberg HS. Hedgehog-signaling is upregulated in non-producing human adrenal adenomas and antagonism of hedgehog-signaling inhibits proliferation of NCI-H295R cells and an immortalized primary human adrenal cell line. J Steroid Biochem Mol Biol. 2014 Jan;139:7-15. Epub 2013 Sep 21.
2013






































Haase M, Willenberg HS.
Hyperandrogenemia. Dtsch Med Wochenschr. 2013 Dec; Epub 2013 Nov 26.
Dekkers T, Deinum J, Schultzekool LJ, Blondin D, Vonend O, Hermus AR, Peitzsch M, Rump LC, Antoch G, Sweep FC, Bornstein SR, Lenders JW, Willenberg HS, Eisenhofer G.
Plasma metanephrine for assessing the selectivity of adrenal venous sampling. Hypertension. 2013 Dec; Epub 2013 Sep 30.
Bernecker C, Hartung B, Maser-Gluth C, Schott M, Willenberg HS.
Development of Cushing's syndrome during phytotherapy. Dtsch Med Wochenschr. 2013 Aug
Jäger F, Willenberg HS.
Hormones and the critically ill. Dtsch Med Wochenschr. 2013 Apr.
Bernecker C, Halim F, Haase M, Willenberg HS, Ehlers M, Schott M.
MicroRNA Expressions in PMBCs, CD4+, and CD8+ T-Cells from Patients Suffering from Autoimmune Addison's Disease. Horm Metab Res. 2013 Apr 15. [Epub ahead of print]
Krausch M, Raffel A, Anlauf M, Schott M, Lehwald N, Krieg A, Kröpil F, Cupisti K, Knoefel WT.
Secondary malignancy in patients with sporadic neuroendocrine neoplasia. Endocrine. 2013 Mar 14. [Epub ahead of print]
Schott M.
Hyperthyroidism. Internist (Berl). 2013 Mar.
Johnson KT, Wiesweg B, Schott M, Ehlers M, Müller M, Minich WB, Nagayama Y, Gulbins E, Eckstein AK, Berchner-Pfannschmidt U.
Examination of Orbital Tissues in Murine Models of Graves' Disease Reveals Expression of UCP-1 and the TSHR in Retrobulbar Adipose Tissues. Horm Metab Res. 2013 Feb 5. [Epub ahead of print]
Erdogan I, Deutschbein T, Jurowich C, Kroiss M, Ronchi C, Quinkler M, Waldmann J, Willenberg HS, Beuschlein F, Fottner C, Klose S, Heidemeier A, Brix D, Fenske W, Hahner S, Reibetanz J, Allolio B, Fassnacht M; German Adrenocortical Carcinoma Study Group.
The role of surgery in the management of recurrent adrenocortical carcinoma. J Clin Endocrinol Metab. 2013 Jan
2012


















































































Dringenberg T, Schwitalla M, Haase M, Scherbaum WA, Willenberg HS.
Control of CYP11B2/CYP11B1 Expression Ratio and Consequences for the Zonation of the Adrenal Cortex. Horm Metab Res. 2012 Dec 12. [Epub ahead of print]
Gruber M, Willenberg HS, Bornstein SR.
New developments in pituitary diseases. Dtsch Med Wochenschr. 2012 Dec
Krausch M, Kroepil F, Lehwald N, Lachenmayer A, Schott M, Anlauf M, Cupisti K, Knoefel WT, Raffel A.
Notch 1 tumor expression is lacking in highly proliferative pancreatic neuroendocrine tumors. Endocrine. 2012 Dec 7. [Epub ahead of print]
Paschali M, Willenberg HS, Fritzen R, Schott M, Scherbaum WA, Schinner S.
False positives on both dexamethasone testing and urinary free cortisol in women on oral contraception: dose-response effects. Clin Endocrinol. 2012 Nov 12.[Epub ahead of print]
Steinbrenner H, Hotze AL, Speckmann B, Pinto A, Sies H, Schott M, Ehlers M, Scherbaum WA, Schinner S:
Localization and regulation of pancreatic selenoprotein P. J Mol Endocrinol. 2012 Nov 2. [Epub ahead of print]
Bramann EL, Willenberg HS, Hildebrandt B, Müller-Mattheis V, Schott M, Scherbaum WA, Haase M:
Griseofulvin Inhibits the Growth of Adrenocortical Cancer Cells In Vitro. Horm Metab Res. 2012 Oct 30. [Epub ahead of print]
Bernecker C, Ostapczuk M, Vordenbäumen S, Ehlers M, Thiel A, Schinner S, Willenberg H, Scherbaum WA, Schott M:
HLA-A2 Phenotype may be Protective Against Graves' Disease but not Against Hashimoto's Thyroiditis in Caucasians. Horm Metab Res. 2012 Sep 12. [Epub ahead of print]
Bernecker C, Lenz L, Ostapczuk MS, Schinner S, Willenberg H, Ehlers M, Vordenbäumen S, Feldkamp J, Schott M:
MicroRNAs -146a1, -155 2, -200a1 are Regulated in Autoimmune Thyroid Diseases. Thyroid. 2012 Sep 7. [Epub ahead of print]
Ehlers M, Papewalis C, Stenzel W, Jacobs B, Meyer KL, Deenen R, Willenberg HS, Schinner S, Thiel A, Scherbaum WA, Ullrich E, Zitvogel L, Schott M:
Immunoregulatory Natural Killer Cells Suppress Autoimmunity by Down-Regulating Antigen-Specific CD8+ T Cells in Mice. Endocrinology. 2012 Jun 25. [Epub ahead of print]
Eisenhofer G, Schott M, Bornstein S: Pheochromocytoma and paraganglioma: recent
progress and new vistas for improved patient care. Horm Metab Res. 2012,44(5):325-7
Vogt S, Winkler E, Hermsen D, Schott M, Schinner S, Scherbaum WA, Willenberg HS:
Endothelin-1 and Adrenomedullin Plasma Levels After Exposure to Fludrocortisone,
Dexamethasone, and Spironolactone. Clin Exp Hypertens. 2012, [Epub ahead of
print]
Fassnacht M, Terzolo M, Allolio B, Baudin E, Haak H, Berruti A, Welin S,
Schade-Brittinger C, Lacroix A, Jarzab B, Sorbye H, Torpy DJ, Stepan V,
Schteingart DE, Arlt W, Kroiss M, Leboulleux S, Sperone P, Sundin A, Hermsen I,
Hahner S, Willenberg HS, Tabarin A, Quinkler M, de la Fouchardière C,
Schlumberger M, Mantero F, Weismann D, Beuschlein F, Gelderblom H, Wilmink H,
Sender M, Edgerly M, Kenn W, Fojo T, Müller HH, Skogseid B; the FIRM-ACT Study
Group: Combination Chemotherapy in Advanced Adrenocortical Carcinoma. N Engl J
Med
. 2012, [Epub ahead of print]
Ehlers M, Thiel A, Bernecker C, Porwol D, Papewalis C, Willenberg HS, Schinner
S, Hautzel H, Scherbaum WA, Schott M: Evidence of a Combined Cytotoxic
Thyroglobulin and Thyroperoxidase Epitope-Specific Cellular Immunity in
Hashimoto's Thyroiditis. J Clin Endocrinol Metab. 2012, 97(4):1347-54
Willenberg HS, Gruber M, Eisenhofer G, Bornstein SR: [Endocrine hypertension:
new aspects and developments]. Dtsch Med Wochenschr. 2012, 137(13):627-30
Bernecker C, West TB, Mansmann G, Scherbaum WA, Willenberg HS: Hypercortisolism
caused by ritonavir associated inhibition of CYP 3A4 under inhalative
glucocorticoid therapy. 2 case reports and a review of the literature. Exp Clin
Endocrinol Diabetes
. 2012, 120(3):125-7
Herrmann LJ, Heinze B, Fassnacht M, Willenberg HS, Quinkler M, Reisch N, Zink M,
Allolio B, Hahner S: TP53 germline mutations in adult patients with
adrenocortical carcinoma. J Clin Endocrinol Metab. 2012, 97(3):E476-85
Saha S, Willenberg HS, Bornstein SR, Graessler J, Kopprasch S: Diabetic
lipoproteins and adrenal aldosterone synthesis--a possible pathophysiological
link? Horm Metab Res. 2012, 44(3):239-44
Kühn MC, Willenberg HS, Schott M, Papewalis C, Stumpf U, Flohé S, Scherbaum WA,
Schinner S: Adipocyte-secreted factors increase osteoblast proliferation and the
OPG/RANKL ratio to influence osteoclast formation. Mol Cell Endocrinol. 2012,
349(2):180-8
2011

















































































Krausch M, Raffel A, Anlauf M, Schott M, Willenberg H, Lehwald N, Hafner D, Cupisti K, Eisenberger CF, Knoefel WT: Loss of PTEN expression in neuroendocrine pancreatic tumors. Horm Metab Res. 2011, 43(12):865-71
Mokosch A, Bernecker C, Willenberg HS, Neumann NJ: [Kallmann syndrome]. Hautarzt. 2011, 62(10):728-30
Raffel A, Krausch M, Roushan K, Anlauf M, Henopp T, Hafner D, Lehwald N, Kröpil F, Schott M, Eisenberger CF, Knoefel WT, Stoecklein NH: Global histone modification pattern predicts poor prognosis in organic hyperinsulinism. Horm Metab Res. 2011, 43(12):858-64
Schott M, Oberg K: Neuroendocrine neoplasms. Horm Metab Res. 2011, 43(12):823-4
Poeppel TD, Binse I, Petersenn S, Lahner H, Schott M, Antoch G, Brandau W, Bockisch A, Boy C: 68Ga-DOTATOC versus 68Ga-DOTATATE PET/CT in functional imaging of neuroendocrine tumors. J Nucl Med. 2011, 52(12):1864-70
Thiel A, Ehlers M, Anlauf M, Raffel A, Stoecklein NH, Schott M: The immune system in neuroendocrine tumors. Horm Metab Res. 2011, 43(12):890-6.
Heller C, Kühn MC, Mülders-Opgenoorth B, Schott M, Willenberg HS, Scherbaum WA, Schinner S: Exendin-4 upregulates the expression of Wnt-4, a novel regulator of pancreatic cell proliferation. Am J Physiol Endocrinol Metab. 2011, 301(5):E864-72
Vleugels K, Schinner S, Krause D, Morawietz H, Bornstein SR, Ehrhart-Bornstein M, Krug AW: ERK1/2 MAPKs and Wnt signaling pathways are independently involved in adipocytokine-mediated aldosterone secretion. Exp Clin Endocrinol Diabetes. 2011, 119(10):644-8
Chavakis T, Kanczkowski W, Willenberg HS, Bornstein SR: Endothelial dysfunction: a critical determinant in inflammation-associated adrenal insufficiency? Eur J Clin Invest. 2011, 41(8):917-9
Bernecker C, Scherr J, Schinner S, Braun S, Scherbaum WA, Halle M: Evidence for an exercise induced increase of TNF-α and IL-6 in marathon runners. Scand J Med Sci Sports. 2011, [Epub ahead of print]
Schinner S, Füth R, Kempf K, Martin S, Willenberg HS, Schott M, Dinh W, Scherbaum WA, Lankisch M: A progressive increase in cardiovascular risk assessed by coronary angiography in non-diabetic patients at sub-diabetic glucose levels. Cardiovasc Diabetol. 2011, 10:56.
Haase M, Schott M, Kaminsky E, Lüdecke DK, Saeger W, Fritzen R, Schinner S, Scherbaum WA, Willenberg HS: Cushing's disease in a patient with steroid 21-hydroxylase deficiency. Endocr J. 2011, 58(8):699-706
Schott M, Klöppel G, Raffel A, Saleh A, Knoefel WT, Scherbaum WA: Neuroendocrine neoplasms of the gastrointestinal tract. Dtsch Arztebl Int. 2011, 108(18):305-12
Willhauck MJ, Schott M, Kreissl MC, Fassnacht M, Spitzweg C: [New therapeutic options for advanced thyroid cancer]. Dtsch Med Wochenschr. 2011, 136(22):1165-8
Anlauf M, Gerlach P, Schott M, Raffel A, Krausch M, Knoefel WT, Pavel M, Klöppel G: [Pathology of neuroendocrine neoplasms]. Chirurg. 2011, 82(7):567-73
Koch A, Hamann L, Schott M, Boehm O, Grotemeyer D, Kurt M, Schwenke C, Schumann RR, Bornstein SR, Zacharowski K: Genetic variation of TLR4 influences immunoendocrine stress response: an observational study in cardiac surgical patients. Crit Care. 2011, 15(2):R109.
Haase M, Anlauf M, Schott M, Schinner S, Kaminsky E, Scherbaum WA, Willenberg HS: A new mutation in the menin gene causes the multiple endocrine neoplasia type 1 syndrome with adrenocortical carcinoma. Endocrine. 2011, 39(2):153-9
Haase M, Willenberg HS, Bornstein SR: Update on the corticomedullary interaction in the adrenal gland. Endocr Dev. 2011, 20:28-37
Späth M, Korovkin S, Antke C, Anlauf M, Willenberg HS: Aldosterone- and cortisol-co-secreting adrenal tumors: the lost subtype of primary aldosteronism. Eur J Endocrinol. 2011, 164(4):447-55
Papewalis C, Jacobs B, Baran AB, Ehlers M, Stoecklein NH, Willenberg HS, Schinner S, Anlauf M, Raffel A, Cupisti K, Fenk R, Scherbaum WA, Schott M. Increased numbers of tumor-lysing monocytes in cancer patients. Mol Cell Endocrinol 2011;337:52–61.
Schinner S, Füth R, Kempf K, Martin S, Willenberg HS, Schott M, Dinh W, Scherbaum WA, Lankisch M. A progressive increase in cardiovascular risk assessed by coronary angiography in non-diabetic patients at sub-diabetic glucose levels. Cardiovasc Diabetol 2011.
Liu C, Scherbaum WS, Schott M und Schinner S: Subclinical hypothyroidism and the prevalence of metabolic syndrome. Horm Metab Res 2011
Papewalis C, Kouatchoua C, Ehlers M, Jacobs B, Porwol D, Schinner S, Willenberg HS, Anlauf M, Raffel A, Eisenhofer G, Neumann HP, Bornstein SR, Scherbaum WA, Schott M. Chromogranin A as potential target for immunotherapy of malignant pheochromocytoma. Mol Cell Endocrinol 2011;335:69–77
Papewalis C, Kouatchoua C, Ehlers M, Jacobs B, Porwol D, Schinner S, Willenberg HS, Anlauf M, Raffel A, Eisenhofer G, Neumann HP, Bornstein SR, Scherbaum WA, Schott M. Chromogranin A as potential target for immunotherapy of malignant pheochromocytoma. Mol Cell Endocrinol 2011;335:69–77
Bernecker C, Scherr J, Schinner  S, Braun S, Scherbaum WA, Halle M
Evidence for an exercise induced increase of TNF- α and IL-6 in marathon runners. Scand J Med Sci Sports in press
2010Raffel A, Eisenberger CF, Cupisti K, Baldus SE, Topp SA, Schulte am Esch J, Peiper J, Schott M, Knoefel WT und Stoecklein NK: Increased EpCAM expression in malignant insulinoma: Potential clinical implication. Eur J Endocrinol. 2010, 162(2):391-8
Hermsen D, Eckstein A, Schinner S, Willenberg HS, Thiel A, Scherbaum WA, Schott M: Reproducibility of Elecsys(R) Anti-TSHR Test Results in a Lot-to-Lot Comparison. Horm Metab Res. 2010, 42(4):295-7
Willenberg HS, Späth M, Maser-Gluth C, Engers R, Anlauf M, Dekomien G, Schott M, Schinner S, Cupisti K, Scherbaum WA: Sporadic solitary aldosterone- and cortisol-cosecreting adenomas – endocrine function tests, histological and geneticfindings in a subtype of primary aldosteronism. Hypertens Res. 2010, 33(5):467-72
Ulgen F, Herder C, Kühn MC, Willenberg HS, Schott M, Scherbaum WA, Schinner S: Association of serum levels of retinol-binding protein 4 with male sex but not with insulin resistance in obese patients. Arch Physiol Biochem. 2010, 116(2):57-62
Erlic Z, Ploeckinger U, Cascón A, Hoffmann MM, von Duecker L, Winter A, Kammel G, Bacher J, Sullivan M, Isermann B, Fischer L, Raffel A, Knoefel WT, Schott M, Baumann T, Schaefer O, Keck T, Baum RP, Milos I, Muresan M, Peczkowska M, Januszewicz A, Cupisti K, Tönjes A, Fasshauer M, Langrehr J, von Wussow P, Agaimy A, Schlimok G, Lamberts R, Wiech T, Schmid KW, Weber A, Nunez M, Robledo M, Eng C, Neumann HP: Systematic comparison of sporadic and syndromic pancreatic islet cell tumors. Endocr Relat Cancer. 2010, 17(4):875-83
Ulgen F, Kühn MC, Cupisti K, Herder C, Willenberg HS, Schott M, Scherbaum WA, Schinner S: The CB-1 Receptor Antagonist Rimonabant Modulates the Interaction Between Adipocytes and Pancreatic Beta-Cells in Vitro. Exp Clin Endocrinol Diabetes. 2010, 119(1):41-6
Balaş M, Zosin I, Maser-Gluth C, Hermsen D, Cupisti K, Schott M, Schinner S, Knoefel WT, Scherbaum WA, Willenberg HS: Indicators of mineralocorticoid excess in the evaluation of primary aldosteronism. Hypertens Res. 2010 Aug;33(8):850-6
Paramonova I, Haase M, Mülders-Opgenoorth B, Ansurudeen-Rafi I, Bornstein SR, Papewalis C, Schinner S, Schott M, Scherbaum WA, Willenberg HS: The effects of the endothelium on adrenal steroidogenesis and growth are mainly mediated by proteins other than endothelin-1. Horm Metab Res. 2010, 42(12):840-5
Zöphel K, Roggenbuck D, Wunderlich G, Schott M: Continuously increasing sensitivity over three generations of TSH receptor autoantibody assays. Horm Metab Res. 2010, 42(12):900-2
Hautzel H, Pisar E, Yazdan-Doust N, Schott M, Beu M, Müller HW: Qualitative and quantitative impact of protective glucocorticoid therapy on the effective 131I half-life in radioiodine therapy for Graves disease. J Nucl Med. 2010, 51(12):1917-22
Björklund P, Cupisti K, Mårten Fryknäs, Isaksson A, Willenberg HS, Åkerström G, Hellman P, Westin G. Microarray expression analysis of human pheochromocytoma: Differential expression of stathmin. Exp Clin Endocrinol Diab 2010;118:27-30.
Adam P, Hahner S, Hartmann M, Heinrich B, Quinkler M, Willenberg HS, Saeger W, Sbiera S, Schmull S, Voelker HU, Ströbel P, Allolio B, Fassnacht M. Epidermal growth factor receptor (EGFR) in adrenocortical tumors - analysis of gene sequence, protein expression and correlation with clinical outcome. Mod Pathol 2010;23:1596–1604
Johanssen S, Hahner S, Saeger W, Quinkler M, Beuschlein F, Dralle H, Haaf M, Kroiss M, Jurowich C, Langer P, Oelkers W, Spahn M, Willenberg HS, Mäder U, Allolio B, Fassnacht M. Deficits in the management of patients with adrenocortical carcinoma in Germany. Dtsch Arztebl Int 2010;107:885–891
Sbiera S, Schmull S, Assié G, Voelker HU, Kraus L, Beyer M, Ragazzon B, Beuschlein F, Willenberg HS, Hahner S, Saeger W, Bertherat J, AllolioB, Fassnacht M. High diagnostic and prognostic value of steroidogenic factor 1 in adrenal tumors. J Clin Endocr Metab 2010;95:E161–E171.
Vordenbäumen S, Schinner S, Halle M, Fischer-Betz R, Schneider M.
Therapy of dyslipidemia in rheumatic diseases Z Rheumatol. 69(8):689-92, 694-5 (2010)
Schinner S. Wnt-signalling in pancreatic beta-cells – more complex than expected. Diabetologia, 53(9):2073-5 (2010).
2009Lehwald N, Cupisti K, Willenberg HS, Schott M, Krausch M, Raffel A, Wolf A, Brinkmann K, Eisenberger CF, Knoefel WT. Standard-radical vs. function-preserving surgery of benign nodular goiter - a sonographic and biochemical 10 years-follow-up study. Langenbeck Arch Surg 2009, 394(2): 279-83
Lachenmayer A, Lichtenauer UD, Cox T, Schott M, Malendowicz LK, Goretzki PE, Cupisti C, Scherbaum WA, Bornstein SR und Willenberg HS: Nestin as a valuable marker in the classification of adrenocortical tumors. Horm Metab Res 2009, 41(5):397-401
Haase M, Ansurudeen I, Paramonova I, Schinner S, Schott M, Papewalis C, Krug A, Scherbaum WA und Willenberg HS: Evidence for the involvement of endothelial cell products in adrenal CITED2 expression. Cell Tissue Res 2009, 336(2):337-43
Gu J, Quan C, Tang W, Wu X, Liu C, Mao X, Xu K, Scherbaum WA, Schott M und Liu C: Polychlorinated Biphenyls affect thyroid function and induce autoimmunity in SD rats. Horm Metab Res 2009, 41(6):471-4 (geteilte Letztautorenschaft)
Papewalis C, Wuttke M, Jacobs B, Willenberg HS, Schinner S, Scherbaum WA und Schott M: Role of the novel mTOR inhibitor RAD001 (Everolimus) in anaplastic thyroid carcinoma Horm Metab Res 2009,41(10):752-6
Menge T, Schloot NC, Schott M, Hemmer B, Wiendl H, Hartung H-P und Kieseier BC: Interferon beta treatment does not induce organ-specific autoantibodies in patients with multiple sclerosis. Neurology 2009, 73(11):900-2
Erlic Z, Rybicki L,  Peczkowska M, Hohenberg W, Kann PH, Dralle H, Müssig K, Muresan M, Schäffler A, Reisch N, Schott M, Fassnacht M, Opocher G, Klose S, Fottner C, Forrer F, Plöckinger U, Peterssen S, Zabolotny D, Januszwicz A, Walz M, Eng C, und Neumann
HPH for the European-American Pheochromocytoma Study Group: Clinical Predictors and Algorithm for the Genetic Diagnosis of Pheochromocytoma Patients. Clin Cancer Res. 2009, 15(20):6378-85
Lehwald N, Cupisti K, Willenberg HS, Schott M, Krausch M, Raffel A, Wolf A, Brinkmann K, Eisenberger CF und Knoefel WT. Standard-radical vs. function-preserving surgery of benign nodular goiter - a sonographic and biochemical 10 years-follow-up study. Langenbecks Arch Surg 2009, 394(2): 279-83 
Erlic Z, Hoffmann MM, Peczkowska M, Harsch I, Schott M, Gabbert E, Valimäki M, Preuss SF, Hasse-Lazar K, Waligorski D, Franke G, Robledo M, Januszewicz A, Eng C and Neumann HPH: Pathogenicity of DNA variants and double mutations in multiple endocrine neoplasia type 2 and von Hippel-Lindau syndrome. J Clin Endocr Metab. 2010, 95(1):308-13
Schott M, Hermsen D, Broecker-Preuss M, Casati M, Camara Mas J, Eckstein A, Gassner D, Golla R, Graeber C, van Helden J, Inomata K, Jarausch J, Kratzsch J, Miyazaki N, Navarro Moreno MA, Murakami T, Roth HJ, Stock W, Yoshimura Noh J, Scherbaum WA und Mann K: Clinical Evaluation of the First Automated TSH Receptor Autoantibody Assay: an International Multicenter Trial. Clin Endocrinol 2009, 71(4):566-73
Fassnacht M, Johanssen S, Quinkler M,  Bucsky P, Willenberg HS, Beuschlein F, Terzolo M, Mueller HH, Hahner S, Allolio B for the German ACC Registry group and the ENSAT ACC working group. Limited prognostic value of the 2004 UICC staging classification for adrenocortical carcinoma – proposal for a revised TNM classification. Cancer 2009;115:243–250.
Ansurudeen I, Willenberg HS, Kopprasch S, Ehrhart-Bornstein M, Bornstein SR. Endothelial factors mediate aldosterone release via PKA-independent pathways. Mol Cell Endocrinol 2009;300:66–70.
Ronchi CL, Sbiera S, Kraus L, Wortmann S, Johanssen S, Adam P, Willenberg HS,  Hahner S, Allolio B, Fassnacht F. Expression of excision repair cross complementing group 1 and  prognosis in adrenocortical carcinoma patients treated with platinum-based chemotherapy. Endocr Rel Cancer 2009;16:907–918.
Luckhaus C, Mahabadi B, Grass-Kapanke B, Jänner M, Willenberg HS, Jäger M, Supprian T, Fehsel K. Blood biomarkers of osteoporosis in mild cognitive impairment and Alzheimer's disease. J Neural Transm 2009;34:123–35.
Ziegler CG, Brown JW, Schally AV, Erler A, Gebauer L, Treszl A, Young L, Fishman LM, Engel JB, Willenberg HS, Petersenn S, Eisenhofer G, Ehrhart-Bornstein M, Bornstein SR. Expression of neuropeptide hormone receptors in human adrenal tumors and cell lines: anti-proliferative effects of peptide analogues. Proc Natl Acad Sci USA 2009;106:15879–15884.
Penna-Martinez M, Ramos-Lopez E, Robbers I, Kahles H, Hahner S, Willenberg HS, Reisch N, Seidl C, Segni M, Badenhoop K. The rs1990760 polymorphism within the IFIH1 locus is not associated with Graves' disease, Hashimoto's thyroiditis and Addison's disease. BMC Medical Genetics 2009;10:126.
Schinner S, Willenberg HS, Schott M, Scherbaum WA.
Pathophysiological aspects of Wnt-signalling in endocrine disease Eur. J. Endocrinol. 2009;160(5):731-7
Schinner S, Krätzner R, Baun D, Dickel C, Blume R, Oetjen E.
Inhibition of human insulin gene transcription by peroxisome proliferator-activated receptor γ and thiazolidinedione oral antidiabetic drugs. Br. J. Pharm. 2009; 157(5):736-45
Schinner S
Wnt Signaling and the Metabolic Syndrom, Horm Metab Res. 2009, 41(2):159-63
2008Willenberg HS, Bahlo M, Schott M, Wertenbruch T, Feldkamp J und Schrbaum WA: Helpful diagnostic markers of steroidogenesis for defining hyperandrogenemia in hirsute woman. Steroids 2008, 73:41-6
Schinner S, Ülgen F, Papewalis C, Schott M, Woelk A, Vidal-Puig A und Scherbaum WA: Regulation of insulin secretion, glucokinase gene transcription and ß-cell proliferation by adipocyte-derived wnt-signaling molecules. Diabetologia 2008, 51:147-54
Jacobs B, Papewalis C, Wuttke M, Ullrich E, Fenk R, Willenberg HS, Schinner S, Cohnen M, Seissler J, Zacharowski K, Scherbaum WA und Schott M: IFNa skews Monocyte Differentiation into CD56+ expressing dendritic cells with potent functional activities in vitro and in vivo. J Immunol 2008, 180:1462-70
Jacobs B, Wuttke M, Papewalis C, Fenk R, Stüssgen C, Schinner S, Seissler J und Schott M: Characterization of monocyte-derived IFNalpha-generated dendritic cells. Horm Metab Res 2008, 40:117-21
Papewalis C, Wuttke M, Jacobs B, Domberg J, Willenberg HS, Baehring T, Cupisti K, Raffel A, Chao L, Fenk R, Seissler J, Scherbaum WA, Schott M. Dendritic cell vaccination induces tumor epitope-specific Th1 immune response in medullary thyroid carcinoma. Horm Metab Res 2008;40:108–116
Domberg J, Chao L, Papewalis C, Pfleger C, Xu K, Willenberg HS, Hermsen D, Scherbaum WA, Schloot NC und Schott M: Circulating chemokines in patients with autoimmune thyroid diseases. Horm Metab Res 2008, 40: 416-21
Papewalis C, Wuttke M, Seissler J, Meyer Y, Kessler C, Jacobs B, Ullrich E, Willenberg HS, Schinner S, Baehring T, Scherbaum WA und Schott M: Dendritic cell vaccination with xenogenic polypeptide hormone induces tumor rejection in neuroendocrine cancer. Clin Cancer Res 2008, 14: 4298-305
Sell MA, Schott M, Tharandt L, Cissewski C, Scherbaum WA und Willenberg HS: Functional central hypothyroidism in the elderly. Aging Clin Exp Res 2008, 20: 207-210
Liu C, Hermsen D, Domberg J, Graeber C, Hautzel H, Duan Y, Xu XF, Liu CP, Nao XD, Cupisti K, Scherbaum WA und Schott M: Comparison of M22-based ELISA and Human-TSH-Receptor-based Luminiscence Assay for the Measurement of Thyrotropin Receptor Autoantibodies in Patients with Thyroid Diseases. Horm Metab Res 2008, 40: 479-483
Ramos-Lopez E, Lange B, Kahles H, Willenberg HS, Meyer G, Penna-Martinez M, Reisch N, Hahner S, Seissler J, Badenhoop K. Insulin gene polymorphisms in type 1 diabetes, Addison's disease and the polyglandular autoimmune syndrome type II. BMC Med Genetics 2008;9:65
Wuttke M, Papewalis C, Meier Y, Kessler C, Jacobs B, Willenberg HS, Kouatchoua C, Seissler J, Baehring T, Scherbaum WA und Schott M: Amino acid-modified calcitonin immunization induces tumor epitope-specific immunity in a transgenic mouse model for medullary thyroid carcinoma. Endocrinology 2008, 149: 5627-5634
Brocker-Preuss M, Sheu SY, Worm K, Feldkamp J, Witte J, Scherbaum WA, Mann K, Schmid KW und Schott M: Expression and mutation analysis of the tyrosine kinase c-kit in poorly differentiated and anaplastic thyroid carcinoma and its possible clinical implication. Horm Metab Res 2008, 40: 685-691
Zhu J, Schott M, Liu R, Liu C, Shen B, Wang Q, Mao X, Yu K, Wu X, Schinner S, Papewalis C, Scherbaum WA und Liu C: Intensive glycemic control lowers plasma visfatin levels in patients with type 2 diabetes. Horm Metab Res 2008; 40: 801-805
Wu X, Schott M *, Liu C, Qian C, Mao X, Xu K, Jiang J, Xu Y, Shen M, Scherbaum WA und Liu C: Statins decrease the aberrant HLA-DR expression on thyrocytes from patients with Hashimoto’s thyroiditis. Horm Metab Res 2008 ,40(12):838-41  (* geteilte Erstautorenschaft mit Wu X)
Willenberg HS, Ansurudeen I, Schebesta K, Haase M, Wess B, Schinner S, Raffel A, Schott M, Scherbaum WA. The endothelium secretes interleukin-6 (IL-6) and induces adrenal IL-6 generation that does not interfere with the effect of endothelial cells on aldosterone synthesis. Exp Clin Endocr Diab 2008;116:S70–74.
Schinner S, Kempf K, Overmann H, Willenberg HS, Schott M, Rose B, Scherbaum WA und Herder C: Association of Impaired glucose metabolism in morbid obesity with hypoadiponectinaemia. Exp Clin Endocr Diab 2008, 116: S64-69
Hermsen D, Liu C, Domberg J, Graeber C, Feldkamp J, Duan y, Xu K, Liu C, Mao X, Scherbaum WA und Schott M: Comparison of a solid phase human versus porcine thyrotropin receptor-based immunoassay for the measurement of thyrotropin receptor antibodies in patients with thyroid diseases. Exp Clin Endocr Diab 2008, 116: S59-63
Willenberg HS, Kolentini C, Quinkler M, Cupisti K, Krausch M, Schott M, Scherbaum WA. The sodium to urinary sodium to (potassium)2 to urinary potassium (SUSPPUP) ratio in primary aldosteronism. Eur J Clin Invest 2009;39:43–50
Eckstein AK, Lösch C, Glowacka D, Schott M, Mann K, Esser J und Morgenthaler NG: Euthyroid and primarily hypothyroid patients develop milder and significantly more asymmetric Graves’ ophthalmopathy. Brit J Ophthalmol 2009, 93(8):1052-6
Hermsen D, Broecker-Preuss M, Casati M, Camara Mas J, Eckstein A, Gassner D, Golla R, van Helden J, Inomata K, Jarausch J, Kratzsch J, Mann K, Miyazaki N, Navarro Moreno MA, Murakami T, Roth HJ, Stock W, Yoshimura Noh J, Scherbaum WA und Schott M: Technical Evaluation of the First Automated Assay for the Detection of TSH Receptor Autoantibodies. Clin Chim Acta 2009, 401(1-2):84-9
Rohrbeck A, Neukirchen J, Rosskopf M, Garcia-Pardillos G, Geddert H, Schwalen A, Gabbert HE, von Haeseler A, Pitschke G, Schott M, Kronenwett R, Haas R, Rohr U-P: Gene expression profiling for molecular discrimination and characterization of laser captured primary lung cancers. J Transl Med 2008, 7;6:69
Ülgen F, Scherbaum WA, Partke HJ, Bornstein SR, Schinner S Intrapancreatic Adipocyte Deposition in a Mouse Model for the Metabolic Syndrome Horm. Metabol. Res. 2008, 40(7):507-9
Willenberg HS, Schinner S, Ansurudeen I New mechanisms to control aldosterone synthesis Horm. Metabol. Res. 2008, 40(7):435-41
Papewalis C, Jacobs B,  Wuttke M, Ullrich E, Baehring T, Fenk R, Willenberg HS, Schinner S, Cohnen M, Seissler J, Zacharowski K, Scherbaum WA, Schott M
IFN-  Skews Monocytes into CD56+-Expressing Dendritic Cells with Potent Functional Activities In Vitro and In Vivo J. Immunol. 2008, 180(3):1462-70
2007Schott M, Willenberg HS, Jung G, Nguyen TB, Knoefel  WT, Scherbaum WA. Identification of occult metastases of medullary thyroid carcinoma by pentagastrin-stimulated intravenous sampling followed by targeted surgery. Clin Endocrinol 2007;66:405–409.
Schott M, Eckstein A, Schinner S, Willenberg HS, Morgenthaler NG und Scherbaum WA: Improved prediction of relapse of Graves’ thyrotoxicosis by combined determination of TSH receptor and thyroperoxidase antibodies. Horm Metab Res 2007, 39:56-61
Haase M, Schott M, Bornstein SR, Malendowicz LK, Scherbaum WA und Willenberg HA: CITED2 is expressed in human adrenocortical cells and regulated by basic fibroblast growth factor. J Endocrinol 2007, 192:459-65
Schinner S, Willenberg HS, Krause D, Schott M, Ehrhart-Bornstein M, Bornstein SR und Scherbaum WA: Adipocyte-derived products induce the transcription of the StAR promoter and stimulate aldosterone and cortisol secretion from adrenocortical cells through the Wnt-signaling pathway. Int J Obesity 2007, 31:564-70
Wertenbruch T, Sagert C, Feldkamp J, Willenberg HS, Groeger C, Scherbaum WA und Schott M: Serum selenium levels in patients with remission and relapse of Graves’ disease. Med Chemistry 2007, 3: 281-4
Tran N, Koch A, Berkels R, Boehm O, Zacharowski PA, Baumgarten G, Knuefermann, Schott M, Kanczkowski W, Bornstein SR, Lightman SL und Zacharowski K: Toll-like receptor 9 expression in murine and human adrenal glands and possible implications during inflammation. J Clin Endocr Metab 2007, 92:2773-83
Korthals M, Safaian N, Maihöfer D, Lara M, Schott M, Papewalis C, Kronenwett R, Kobbe G, Haas R und Fenk R: Monocyte-derived dendritic cells generated by IFN-alpha acquire mature dendritic and natural killer cell properties as shown by gene expression analysis. J Transl Med 2007, 25:46
Cupisti K, Wolf A, Raffel A, Schott M, Miersch D, Yang Q, Eisenberger CF, Roher HD und Knoefel WT: Long term clinical follow up in medullary thyroid carcinoma: A single institution’s experience over 20 years. Ann Surg 2007, 246:815-821
Ansurudeen I, Kopprasch S, Ehrhart-Bornstein M, Willenberg HS, Funk RHW, Krug AW, Bornstein SR. Vascular-adrenal niche – endothelial cell-mediated sensitization of human adrenocortical cells to angiotensin II. Horm Metab Res 2006;38:476–480.
Ansurudeen I, Kopprasch S, Ehrhart-Bornstein M, Bornstein SR, Willenberg HS. Endothelial cell-mediated regulation of aldosterone release from human adrenocortical cells. Mol Cell Endocrinol 2007;265–266:150–156.
Schinner S, Fritzen R, Schott M, Willenberg HS, Scherbaum WA. Spontaneous Remission of primary Hyperparathyreoidism Exp. Clin. Endocrinol. Diabetes. 2007, 115(9):619-21
Schott M, Sagert C, Willenberg HS, Schinner S, Ramp U, Varro A, Raffel A, Eisenberger C, Zacharowski K, Perren A, Scherbaum WA.
Carcinogenic Hypergastrinemia: Signet ring cell carcinoma in a patient with multiple endocrine neoplasia type 1 with Zollinger-Ellison’s Syndrome J Clin Endocrin Metab. 2007, 92(9):3378-82
Krug AW, Vleugels K, Schinner S, Lamounier-Zepter V, Ziegler CG, Bornstein SR, Ehrhart-Bornstein M.
Human adipocytes induce an ERK1/2 MAP kinases-mediated upregulation of steroidogenic acute regulatory protein (StAR) and an angiotensin II — sensitization in human adrenocortical cells Int. J. Obes. 2007, 31(10):1605-16
2006Papewalis C, Fassnacht M, Domberg J, Willenberg HS, Schinner S, Bornstein SR, Scherbaum WA und Schott M: Dendritic cells as potential adjuvant for immunotherapy in adrenocortical carcinoma. Clin Endocrinol 2006, 65:215-22
Willenberg HS, Schott M, Saeger W, Tries A, Scherbaum WA und Bornstein SR: Expression of connexins in chromaffin cells of normal human adrenals, benign and malignant pheochromocytomas. Ann NY Acad Sci 2006, 1073:578-83
Christodulides C, Laudes M, Cawthorn WP, Schinner S, Soos M, O`Rahilly S, Sehti JK, Vidal-Puig AJ..The Wnt antagonist Dickkopf-1 and its receptors are coordinately regulated during early human adipogenesis. J Cell Sci . 2006,119, 2613-2620
2005Schott M, Minich WB, Willenberg H, Fritzen R, Papewalis C, Schinner S, Seissler J, Scherbaum WA und Morgenthaler NG: Relevance of TSH receptor stimulating and blocking autoantibodies measurement for the prediction of relapse in Graves’ disease. Horm Metab Res 2005, 37:741-4
Willenberg HS, Haase M, Papewalis C, Schott M, Scherbaum WA und Bornstein SR: Corticotropin-releasing hormone (CRH) receptor expression on normal and tumorous human adrenocortical cells. Neuroendocrinology 2005, 82:274-81
Schinner S, Barthel A, Dellas C, Grzeskowiak R, Sharma SK, Oetjen E, Blume R, Knepel W. Protein Kinase B activity is sufficient to mimic the effect of insulin on glucagon gene transcription. J. Biol. Chem. 2005, 280(8):7369-76
Schinner S, Scherbaum WA, Bornstein SR, Barthel A.  Molecular mechanisms of insulin resistance.Diabet. Med. 2005, 22(6):674-82
Schinner S, Bornstein SR. Cortico-Chromaffin Cell Interaction in the adrenal gland.Endocr. Path. 2005, 16(2):91-8
2004Schott M, Morgenthaler NG, Fritzen R, Feldkamp J, Willenberg HS, Scherbaum WA und Seissler J: Levels of autoantibodies against human TSH receptor predict relapse of hyperthyroidism in Graves’ disease. Horm Metab Res 2004, 36(2):92-96
Rohr U B, Rehfeld N, Pflugfelder L, Geddert H, Steidl U, Fenk R, Gräf T, Schott M, Thiele K P, Gabbert H E, Germing U, Kronenwett R und Haas R: Expression of tyrosine kinase c-kit is an independent prognostic factor in patients with small cell lung cancer. Int J Cancer 2004, 111(2):259-63
Seres J, Bornstein SR, Seres P, Willenberg HS, Schulte KM, Scherbaum WA, Ehrhart-Bornstein M. Corticotropin-releasing hormone system in human adipose tissue. J Clin Endocrinol Metab 2004;89:965–970.
Walters RJ, Brandt MV, Nastos A, Hiroi N, Willenberg HS, Oeff MK, Scherbaum WA, Bornstein SR. Insulin modulates the expression levels of dopamine-beta-hydroxylase and phenylethanolamine N-methyl-transferase within PC12 cells. Cellscience 2004
George S, Rochford JJ, Wolfrum C, Gray SL, Schinner S, Wilson JC, Soos MA, Murgatroyd PM, Williams RM, Acerini CL, Dunger DB, Barford D, Umpleby MA,  Wareham NJ, Davies HA, Schafer AJ, Stoffel M, O’Rahilly S, Barroso I. A family with severe insulin resistance and diabetes due to a mutation in AKT2.Science 2004, 304(5675):1325-8
Rochford JJ, Semple RK, Laudes M, Boyle KB, Christodoulides C, Mulligan C, Lelliott CJ, Schinner S, Hadaschik D, Mahadevan M, Sethi JK, Vidal-Puig A, O'Rahilly S.ETO/MTG8 Is an Inhibitor of C/EBP{beta} Activity and a Regulator of Early Adipogenesis.Mol Cell Biol.2004, 24(22):9863-9872
2003Krüger T, Wohlrab U, Klucken M, Schott M und Seissler J: Autoantigen-specific protein of non-obese diabetic mice from cyclophosphamide-accelerated diabetes by vaccination with dendritic cells. Diabetologia 2003, 46:1357-1365
Beery E, Middel P, Bahn A, Willenberg HS, Hagos Y, Koepsell H, Bornstein SR, Muller GA, Burckhardt G, Steffgen J. Molecular evidence of organic ion transporters in the rat adrenal cortex with adrenocorticotropin-regulated zonal expression. Endocrinology 2003;144:4519–4526.
Ehrhart-Bornstein M, Lamounier-Zepter V, Schraven A, Langenbach J, Willenberg HS, Barthel A, Hauner H, McCann SM, Scherbaum WA, Bornstein SR. Human adipocytes secrete mineralocorticoid releasing factors. Proc Natl Acad Sci USA 2003;100:14211–14216.
Meirhaeghe A, Crowley V, Lenaghan C, Lelliott C, Green K, Stewart A, Hart K, Schinner S, Sethi JK, Yeo G, Brand MD, Cortright RN, O'Rahilly S, Montague C, Vidal-Puig AJ. Characterization of the human, mouse and rat PGC1 beta (peroxisome-proliferator-activated receptor-gamma co-activator 1 beta) gene in vitro and in vivo. Biochem J. 2003, 373(Pt 1): 155-65
2002Seissler J, Eikamp K, Schott M und Scherbaum WA: IA-2 Autoantibodies restricted to the IgG4 Subclass are Associated with Protection from Type 1 Diabetes. Horm Metab Res 2002, 34(4):186-191
Schott, M, Feldkamp, J, Klucken, M, Kobbe, G, Scherbaum, WA. und Seissler J: Calcitonin-specific antitumor immunity in medullary thyroid carcinoma following dendritic cell vaccination. Cancer Immunol Immun 2002, 51:663-668
Wagner S, Aust G, Schott M, Scherbaum WA, Feldkamp J. und Seissler J: Regulation of Sodium-iodide-symporter gene expression in human thyrocytes measured by real-time polymerase chain reaction. Exp Clin Endocr Diab 2002, 110:398-402
Willenberg HS, Mansman NG, Fritzen R, Schott M, Feldkamp J, Schulte HM, Scherbaum WA und Bornstein SR: The short synacthen test in the evaluation of adrenal masses in patients with malignancies. Endocr Res 2002, 28:793-7
Willenberg HS, Päth G, Vögeli TA, Scherbaum WA, Bornstein SR. Role of Interleukin-6 in the stress response in normal and tumorous adrenal cells and during chronic inflammation. Ann N Y Acad Sci 2002;966:304–314.
Walters RJ, Rosenbaum C, Willenberg HS, Scherbaum WA, Bornstein SR. Insulin, nerve growth factor and PACAP modulate the expression of GABAA subunits in PC12 cells. Neuroscience; Epup November 1st 2002
Mossner R, Schulz U, Kruger U, Middel P, Schinner S, Fuzesi L, Neumann C, Reich K. Agonists of peroxisome proliferator-activated receptor gamma inhibit cell growth in malignant melanoma. J Invest Dermatol. 2002, 119(3):576-82
Schinner S, Dellas C, Schröder M, Heinlein C, Chang C, Fischer J, Knepel W. Repression of glucagon gene transcription by PPAR though inhibition of Pax6 transcriptional activity. J. Biol. Chem. 2002, 277(3):1941-8
2001Feldkamp J, Pascher E, Schott M, Seissler J, und Scherbaum WA: Soluble Fas is increased in hyperthyroidism independent of the underlying thyroid disease. J Clin Endocr Metab 2001, 86(9):4520-4253
Schott M, Seissler J, Lettmann M, Fouxon V, Scherbaum WA und Feldkamp J: Immunotherapy for medullary thyroid carcinoma by dendritic cell vaccination. J Clin Endocinol Metab 2001, 86:4965-9
Maurer M, Trajanoski Z, Frey G, Hiroi N, Galon J, Willenberg HS, Gold PW, Chrousos GP, Scherbaum WA, Bornstein SR. Differential gene expression profile of glucocorticoids, testosterone, and dehydroepiandrosterone in human cells. Horm Metab Res 2001;33:691–695.
2000Schott M, Feldkamp J, Bathan C, Fritzen R, Scherbaum WA und Seissler J: Detecting TSH-receptor antibodies with the recombinant TBII assay: Technical and clinical evaluation. Horm Metab Res 2000, 32:429-435
Schattenberg D, Schott M, Reindl G, Krueger T, Tschoepe D, Feldkamp J, Scherbaum WA und Seissler J: Response of human monocyte-derived dendritic cells to immunostimulatory DNA. Eur J Immunol 2000, 30 (10):2824-31
Seissler J, Schott M, Morgenthaler NG und Scherbaum WA: Mapping of novel autoreactive epitopes of the diabetes-associated autoantigen IA-2. Clin Exp Immunol 2000, 122:157-63
Seissler J, Wagner S, Schott M, Lettmann M, Feldkamp J, Scherbaum WA und Morgenthaler NG: Low frequency of autoantibodies to the human Na+/J-symporter (NIS) in patients with autoimmune thyroid disease. J Clin Endocr Metab 2000, 85 (12):4630-4
Willenberg HS, Bornstein SR, Hiroi N, Päth G, Goretzki PE, Scherbaum WA, Chrousos GP. Effects of a novel corticotropin-releasing-hormone receptor type 1 antagonist on human adrenal function. Mol Psych 2000;5:137–141.
1999Stratakis CA, Carney JA, Kirschner LS, Willenberg HS, Brauer S, Ehrhart-Bornstein M, Bornstein SR. Synaptophysin immunoreactivity in primary pigmented nodular adrenocortical disease: neuroendocrine properties of tumors associated with Carney complex. J Clin Endocrinol Metab 1999;84:1122–1128.
Seissler J, Schott M, Steinbrenner H, Peterson P, Krohn KJE und Scherbaum WA: Autoantibodies to adrenal cytochrome P450 antigens in isolated Addison’s disease and autoimmune polyglandular syndrome type II. Exp Clin Endocr Diab 1999, 107:208-13
Seissler J, Schott M, Boms S, Wohlrab U, Ostendorf B, Morgenthaler NG und Scherbaum WA: Autoantibodies to tissue transglutaminase identify silent coeliac diesase in type 1 diabetes. Diabetologia 1999; 42:1440-41
Schott M, Seissler J, Feldkamp J, von Schilling C und Scherbaum WA: Dendritic cell immunotherapy induces antitumor response in parathyroid carcinoma and neuroendocrine pancreas carcinoma. Horm Metab Res 1999, 31:662-664
1998Schott M, Schatz D, Atkinson M, Krischer J, Mehta H, Vold B und Maclaren N: GAD65Autoantibodies Increase the Predictibility but not the Sensitivity of Islet Cell and Insulin Autoantibodies for Developing Insulin Dependent Diabetes Mellitus. J Autoimmun 1994, 7:865-872
Willenberg HS, Stratakis CA, Marx C, Ehrhart-Bornstein M, Chrousos GP, Bornstein SR. Aberrant interleukin-1 receptors in a cortisol-secreting adrenal adenoma causing Cushing's syndrome. N Eng J Med 1998;339:27–31.
Willenberg HS, Bornstein SR, Dumser T, Ehrhart-Bornstein M, Barocka A, Chrousos GP, Scherbaum WA. Morphologic changes in adrenals from victims of suicide in relation to altered apoptosis. Endocr Res 1998;3/4:963–967.
 
  • bitte hier klicken um diese Seite zu druckenSeite drucken
  • Zuletzt aktualisiert am 29.06.2016
  • URL zur aktuellen Seite: http//www.uniklinik-duesseldorf.de/de/unternehmen/kliniken/klinik-fuer-endokrinologie-und-diabetologie/funktionsbereich-spezielle-endokrinologie/forschung/veroeffentlichungen/